THINGS are about to change for the better at the USPTO because upcoming SCOTUS cases won't challenge Alice (applicable to software patents) but instead jeopardise other kinds of patents.
"We must understand that when it comes to patents the quantity (the more, the merrier) and quality (more is less or less is more) should be grounded on evidence-based analysis, not Battistellite 'logic' and Republican instincts.""Yesterday's Supreme Court ruling," he later added, "means design patents won't spell doom for alleged infringers anymore, but a lot depends on the Fed. Circuit" (CAFC). "The Supreme Court said what the Fed. Cir. got wrong; but now the same Fed. Cir still has to get it right," he continued. "In 2017, we'll see what happens." As we noted here before, only the lawyers win in these disputes that last half a decade or longer.
IAM always complains when patent scope is restricted and this time was no exception; they're hardly even closeted about their patent maximalist bias.
The net outcome here is a major loss for another kind of patent. We must understand that when it comes to patents the quantity (the more, the merrier) and quality (more is less or less is more) should be grounded on evidence-based analysis, not Battistellite 'logic' and Republican instincts. The EPO now moves in the opposite direction, broadening patent scope rather than tightening it.
SCOTUS is going to tackle another kind of patents quite soon (Life Technologies Corp. v Promega Corp.), as an article by Dennis Crouch, another from MIP, and more from patents-centric sites state with concern. Many articles have appeared in recent days and most of them are from the patent microcosm. We too mentioned this case before.
We continue to worry that Trump-appointed Justices (new appointees) to SCOTUS will ruin all/most of the patent progress made in recent years. Conservative think tanks, for example, are out in full force calling for the end of Alice as we know it. We'll cover that separately later tonight. ⬆